Show simple item record

National sociodemographic disparities in the treatment of highâ risk prostate cancer: Do academic cancer centers perform better than community cancer centers?

dc.contributor.authorMahal, Brandon A.
dc.contributor.authorChen, Yu‐wei
dc.contributor.authorMuralidhar, Vinayak
dc.contributor.authorMahal, Amandeep R.
dc.contributor.authorChoueiri, Toni K.
dc.contributor.authorHoffman, Karen E.
dc.contributor.authorHu, Jim C.
dc.contributor.authorSweeney, Christopher J.
dc.contributor.authorYu, James B.
dc.contributor.authorFeng, Felix Y.
dc.contributor.authorKim, Simon P.
dc.contributor.authorBeard, Clair J.
dc.contributor.authorMartin, Neil E.
dc.contributor.authorTrinh, Quoc‐dien
dc.contributor.authorNguyen, Paul L.
dc.date.accessioned2016-11-18T21:24:06Z
dc.date.available2018-01-08T19:47:53Zen
dc.date.issued2016-11-15
dc.identifier.citationMahal, Brandon A.; Chen, Yu‐wei ; Muralidhar, Vinayak; Mahal, Amandeep R.; Choueiri, Toni K.; Hoffman, Karen E.; Hu, Jim C.; Sweeney, Christopher J.; Yu, James B.; Feng, Felix Y.; Kim, Simon P.; Beard, Clair J.; Martin, Neil E.; Trinh, Quoc‐dien ; Nguyen, Paul L. (2016). "National sociodemographic disparities in the treatment of highâ risk prostate cancer: Do academic cancer centers perform better than community cancer centers?." Cancer 122(21): 3371-3377.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/134471
dc.publisherWiley Periodicals, Inc.
dc.subject.otheracademic center
dc.subject.othercommunity center
dc.subject.otherdisparities
dc.subject.otherNational Cancer Data Base
dc.subject.otherpatterns of care
dc.subject.otherprostatic neoplasm
dc.titleNational sociodemographic disparities in the treatment of highâ risk prostate cancer: Do academic cancer centers perform better than community cancer centers?
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134471/1/cncr30205.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134471/2/cncr30205_am.pdf
dc.identifier.doi10.1002/cncr.30205
dc.identifier.sourceCancer
dc.identifier.citedreferenceMahal BA, Aizer AA, Ziehr DR, et al. The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act. Prostate Cancer Prostatic Dis. 2014; 17: 273 â 279.
dc.identifier.citedreferenceBarocas DA, Gray DT, Fowke JH, et al. Racial variation in the quality of surgical care for prostate cancer. J Urol. 2012; 188: 1279 â 1285.
dc.identifier.citedreferenceZeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEERâ Medicare trends 1991 to 1999. Urology. 2004; 64: 1171 â 1176.
dc.identifier.citedreferenceNational Cancer Institute. Cancer Health Disparities. Available at: http://www.cancer.gov/about-nci/organization/crchd/cancer-health-disparities-fact-sheet#q16. Accessed September 4, 2015.
dc.identifier.citedreferenceSiegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5 â 29.
dc.identifier.citedreferenceByers T, Mouchawar J, Marks J, et al. The American Cancer Society challenge goals. How far can cancer rates decline in the US by the year 2015? Cancer. 1999; 86: 715 â 727.
dc.identifier.citedreferenceWard E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54: 78 â 93.
dc.identifier.citedreferenceRyoo JJ, Ordin DL, Antonio AL, et al. Patient preference and contraindications in measuring quality of care: what do administrative data miss? J Clin Oncol. 2013; 31: 2716 â 2723.
dc.identifier.citedreferenceSchulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians’ recommendations for cardiac catheterization. N Engl J Med. 1999; 340: 618 â 626.
dc.identifier.citedreferenceUnderwood W, De Monner S, Ubel P, Fagerlin A, Sanda MG, Wei JT. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol. 2004; 171: 1504 â 1507.
dc.identifier.citedreferenceHede K. Agencies look to patient navigators to reduce cancer care disparities. J Natl Cancer Inst. 2006; 98: 157 â 159.
dc.identifier.citedreferenceMoy B, Chabner BA. Patient navigator programs, cancer disparities, and the patient protection and affordable care act. Oncologist. 2011; 16: 926 â 929.
dc.identifier.citedreferenceNational Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer, 2014. Available at: http://www.nccn.org. Accessed December 30, 2013.
dc.identifier.citedreferenceBilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008; 15: 683 â 690.
dc.identifier.citedreferenceNational Cancer Institute. National Cancer Institute Community Oncology Research Program. Available at: http://ncorp.cancer.gov/about/. Accessed March 1, 2016.
dc.identifier.citedreferenceMahal BA, Aizer AA, Ziehr DR, et al. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups. Urology. 2014; 84: 386 â 392.
dc.identifier.citedreferenceKent EE, Mitchell SA, Castro KM, et al. Cancer care delivery research: building the evidence base to support practice change in community oncology. J Clin Oncol. 2015; 33: 2705 â 2711.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.